Ursodeoxycholic Acid Improves Bilirubin but Not Albumin in Primary Biliary Cirrhosis: Further Evidence for Nonefficacy

Background/Aim. In randomised controlled trials (RCTs) of ursodeoxycholic acid (UDCA), although serum bilirubin is frequently reduced, its effect on disease progression and mortality is unclear. As serum albumin is an established independent prognostic marker, one might expect less deterioration of...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsochatzis, Emmanuel A., Feudjo, Maurille, Rigamonti, Cristina, Vlachogiannakos, Jiannis, Carpenter, James R., Burroughs, Andrew K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3741702/
https://www.ncbi.nlm.nih.gov/pubmed/23984317
http://dx.doi.org/10.1155/2013/139763

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3741702/
https://www.ncbi.nlm.nih.gov/pubmed/23984317
http://dx.doi.org/10.1155/2013/139763

Ejemplares similares